Temperature excursions during shipment and storage

Pharmaceutical Stress Testing: Predicting Drug Degradation: Second Edition

Volumn , Issue , 2016, Pages 583-593

  Zahn, Manuel ^a  

^a 3R Pharma Consulting GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881240034     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781439801802-27     Document Type: Chapter

References (15)

1. Guidance for Industry: INDs for Phase 2 and Phase 3 Studies, Chemistry, Manufacturing, and Controls Information, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) May 2003.
2. Waterman KC, Carella AJ, Gumkowski MJ, et al. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms. Pharm Res 2007; 24 (4): 780-90.
3. Waterman KC, MacDonald BC. Package selection for moisture protection for solid oral drug products. J Pharm Sci 2010; (online edition).
4. Haynes JD. Worldwide virtual temperatures for product stability testing. J Pharm Sciences 1971; 60:927-9.
5. Grimm W, Schepky G. Stabilitätsprüfung in der Pharmazie. Aulendorf: Editio Cantor Verlag, 1980.
6. Allen PV et al. Determination of release limits: a general methodology. Pharm Res 1991; 8(9).
7. Research Project No. AR- 4-28, Saudi Arabia (1992-1995); Research Team: Al- Shareef, A, Khalil, S. A. H., Madani, S. and Shah, A.
8. US 21 CFR 211.142
9. (cGMP for finished pharmaceuticals); CFR 203.32 (prescription drug marketing- drug sample storage and handling requirements); CFR 205.50 (Guidelines for state licensing of wholesale prescription drug distributors-minimum requirements for the storage and handling of prescription drugs and for the establishment and maintenance of prescription drug distribution records).
10. Health Products and Food Branch Inspectorate (Canada) Guidelines for temperature control of drug products during storage and transportation, GUI-0069, January 28, 2011.
11. Good Storage and Shipping Practices USP <1079>.
12. Good distribution practices for pharmaceutical products-WHO technical report series, 2006, No 937, Annex 5, 179-203.
13. Guidance for medicinal products maintaining the quality of temperature-sensitive medicinal products through the transportation environment. PDA Technical Report 39 revised 2007.
14. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, and Guidelines on good distribution practice of medicinal products for human use (94/C 63/03).
15. Guide to control and monitoring of storage and transportation temperature conditions for medicinal products and active substances, edition IND-003 version 01, March 2006 (this guide is based on a publication by John Taylor of the UK MCA. Pharm J 2001; 267: 128-31).